Formulation

Nov 02, 2016
Pharmaceutical Technology
This article will clarify reasonable expectations for the responsibilities of topical product formulation developers and for excipient suppliers regarding the information and samples for experiments needed for QbD.
Oct 05, 2016
By Pharmaceutical Technology Editors
The OptiForm Solution Suite platform offers easy, simple, fast, and cost-effective approaches for both small and macromolecules in early development phases.
Oct 05, 2016
By Pharmaceutical Technology Editors
Capsugel’s intrinsically enteric capsule technology provides enteric protection and delayed release without a functional coating. Merck KGaA’s Parteck SRP 80 sustained-release excipient is well suited for direct compression.
Oct 02, 2016
Pharmaceutical Technology
Understanding the components of a reference marketed pMDI is needed to develop a generic pMDI.
Oct 02, 2016
Pharmaceutical Technology
Excipients play a crucial role in the manufacturing of solid-dosage forms and the performance of the finished drug product.
Oct 02, 2016
Pharmaceutical Technology
This article will equip the excipient vendor with an understanding of QbD from the perspective of the topical pharmaceutical product manufacturer.
Sep 02, 2016
Pharmaceutical Technology
Nanoparticulate technologies are showing promising potential in delivering both small-molecule drugs and biomacromolecules across the blood brain barrier.
Sep 01, 2016
Pharmaceutical Technology
The authors review the regulatory changes associated with the use of dimethyl sulfoxide in finished pharmaceutical dosage forms.
Sep 01, 2016
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Analytics and science-based approaches are shedding more light on these complex dosage forms, promising to improve process control and product design.
Sep 01, 2016
Pharmaceutical Technology
IPEC consultant Irwin Silverstein discusses third-party audits and regulatory compliance issues facing suppliers and their customers.
native1_300x100
lorem ipsum